Fact CheckerSign in

NCT05928598Active, not recruiting

Goals for Epilepsy Clinic Visits Trial

Drug-Resistant Epilepsy (DRE) Goals for Epilepsy Clinical Visits mHealth Epilepsy Visit Planner Trial

Source: ClinicalTrials.gov · Last updated 15 Oct 2026

Brief summary (registry, in English)

The purpose of this project is to conduct a trial to assess whether patients that receive a tablet-based waiting room priority communication tool (the "Epilepsy Visit Planner") have improved outcomes compared to patients that do not receive the tool. The project's hypotheses are: * Patients that receive the Epilepsy Visit Planner will have improved patient-provider communication compared to the non-planner group. * Patients that receive the Epilepsy Visit Planner will have improved quality of life scores. * The Epilepsy Visit Planner will score highly on process measures of feasibility and acceptability, demonstrating suitability for future larger scale study. Additionally, there is a related survey project that is not part of the clinical trial and will not be included in this registration information.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
152 (estimated)
First submitted
21 Jun 2023
Start date
27 Sept 2023
Primary completion date
22 Jul 2026
Lead sponsor
University of Michigan
Diseases
Epilepsy
NCT number
NCT05928598

What you commit to

  • Study type: Interventional
  • Planned participants: 152
  • From 27 Sept 2023 to the primary completion date, 22 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Do not clearly have drug-resistant epilepsy
  • Moderate-to-severe cognitive impairment that precludes study questionnaire completion
  • -Not University of Michigan epilepsy providers

Age

  • \<18 years old

Other

  • Non-English speaking

Who the study is looking for

  • Adults with drug-resistant epilepsy
  • Participants receiving care through the Epilepsy clinics at the University of Michigan
  • -University of Michigan epilepsy providers

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Michigan
Coordinator of this site? Confirm its status
Ann ArborUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.